Literature DB >> 16824127

The Tower of Babel of CD8+ T-cell memory: known facts, deserted roads, muddy waters, and possible dead ends.

Benedita Rocha1, Corinne Tanchot.   

Abstract

Adequate antigen stimulation can lead to permanent modifications of primed cells and to the generation of memory T cells that have astonishingly improved capacities to deal with antigen. The overall properties of memory T cells (increased survival, precocious and increased division capacities, and improved effector functions) can be used to identify this unique cell type. However, each immune response may lead to the generation of multiple primed types that do not necessarily possess all these characteristics. It is not known whether these different cell types are just side products of the immune reaction or whether they are involved in disease control. Control of different infections may involve different challenges and lead to the generation of different types of immune reactions. Our major challenge is to unravel this complexity, but we must overcome our handicapped experimental tests and our imperfect a priori definitions.

Entities:  

Mesh:

Year:  2006        PMID: 16824127     DOI: 10.1111/j.0105-2896.2006.00378.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  17 in total

Review 1.  A spatial view of the CD8+ T-cell response: the case of HCV.

Authors:  Vito Racanelli; Patrizia Leone; Arash Grakoui
Journal:  Rev Med Virol       Date:  2011-07-05       Impact factor: 6.989

Review 2.  The integration of T cell migration, differentiation and function.

Authors:  David Masopust; Jason M Schenkel
Journal:  Nat Rev Immunol       Date:  2013-04-19       Impact factor: 53.106

3.  CCR6: a biomarker for Alzheimer's-like disease in a triple transgenic mouse model.

Authors:  Sandhya Subramanian; Patricia Ayala; Teri L Wadsworth; Christopher J Harris; Arthur A Vandenbark; Joseph F Quinn; Halina Offner
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 4.  Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy.

Authors:  Joseph G Crompton; Madhusudhanan Sukumar; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

Review 5.  Memory CD8+ T cell differentiation in viral infection: a cell for all seasons.

Authors:  Henry Radziewicz; Luke Uebelhoer; Bertram Bengsch; Arash Grakoui
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

Review 6.  Profile of a serial killer: cellular and molecular approaches to study individual cytotoxic T-cells following therapeutic vaccination.

Authors:  Emanuela M Iancu; Petra Baumgaertner; Sébastien Wieckowski; Daniel E Speiser; Nathalie Rufer
Journal:  J Biomed Biotechnol       Date:  2010-11-14

7.  Visualizing early splenic memory CD8+ T cells reactivation against intracellular bacteria in the mouse.

Authors:  Marc Bajénoff; Emilie Narni-Mancinelli; Frédéric Brau; Grégoire Lauvau
Journal:  PLoS One       Date:  2010-07-12       Impact factor: 3.240

8.  Phenotype and functional characterization of long-term gp100-specific memory CD8+ T cells in disease-free melanoma patients before and after boosting immunization.

Authors:  Edwin B Walker; Daniel Haley; Ulf Petrausch; Kevin Floyd; William Miller; Nelson Sanjuan; Greg Alvord; Bernard A Fox; Walter J Urba
Journal:  Clin Cancer Res       Date:  2008-08-15       Impact factor: 12.531

9.  Aberrant lymphocyte activation precedes delayed virus-specific T-cell response after both primary infection and secondary exposure to hepadnavirus in the woodchuck model of hepatitis B virus infection.

Authors:  Shashi A Gujar; Adam K Jenkins; Clifford S Guy; Jinguo Wang; Tomasz I Michalak
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

10.  Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.

Authors:  Jonathan A Gutman; Cameron J Turtle; Thomas J Manley; Shelly Heimfeld; Irwin D Bernstein; Stanley R Riddell; Colleen Delaney
Journal:  Blood       Date:  2009-10-12       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.